A New Horizon in Nephrology: Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
Comments Off on A New Horizon in Nephrology: Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
July 18, 2026
In a landmark development for nephrology, a major international clinical trial has revealed that the drug finerenone can significantly slow the progression of chronic kidney disease (CKD) in patients who do not suffer from diabetes. This breakthrough,…
Breakthrough in Neuro-Oncology: Vitamin B12 Derivative Shows Promise Against Glioblastoma
Comments Off on Breakthrough in Neuro-Oncology: Vitamin B12 Derivative Shows Promise Against Glioblastoma
July 1, 2026
Glioblastoma multiforme (GBM) has long been considered the "final frontier" of oncology. As the most aggressive and malignant form of primary brain cancer, its clinical prognosis remains grim. Despite the aggressive standard-of-care…
